Plegridy Interactions
There are 335 drugs known to interact with Plegridy (peginterferon beta-1a), along with 9 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 14 are major, 320 are moderate, and 1 is minor.
- View all 335 medications that may interact with Plegridy
- View Plegridy alcohol/food interactions (1)
- View Plegridy disease interactions (9)
Most frequently checked interactions
View interaction reports for Plegridy (peginterferon beta-1a) and the medicines listed below.
- Afinitor Disperz (everolimus)
- amitriptyline
- amlodipine
- Ampyra (dalfampridine)
- atorvastatin
- Aubagio (teriflunomide)
- baclofen
- Bactrim DS (sulfamethoxazole / trimethoprim)
- Betaseron (interferon beta-1b)
- bupropion
- Cayston (aztreonam)
- cephalexin
- Copaxone (glatiramer)
- Cymbalta (duloxetine)
- Eloctate (antihemophilic factor)
- gabapentin
- Gilenya (fingolimod)
- Lasix (furosemide)
- levothyroxine
- Lipitor (atorvastatin)
- lisinopril
- losartan
- Lyrica (pregabalin)
- methotrexate
- Ocrevus (ocrelizumab)
- pantoprazole
- prednisone
- Tecfidera (dimethyl fumarate)
- tizanidine
- Vitamin D3 (cholecalciferol)
Plegridy alcohol/food interactions
There is 1 alcohol/food interaction with Plegridy (peginterferon beta-1a).
Plegridy disease interactions
There are 9 disease interactions with Plegridy (peginterferon beta-1a) which include:
- hepatic disease
- autoimmune disorders
- congestive heart failure
- decrease blood counts
- depression
- injection site reaction
- renal dysfunction
- seizures
- thrombotic microangiopathy
Report options
QR code containing a link to this page
More about Plegridy (peginterferon beta-1a)
- Plegridy consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (14)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: interferons
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.